US Stock MarketDetailed Quotes

Iovance Biotherapeutics (IOVA)

Watchlist
  • 4.090
  • +0.110+2.76%
Close May 6 16:00 ET
  • 4.080
  • -0.010-0.24%
Post 19:59 ET
1.83BMarket Cap-3.75P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Iovance Biotherapeutics (IOVA) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
14.33%-302.41M
28.28%-52.57M
-33.45%-78.7M
31.48%-67.45M
15.20%-103.69M
2.44%-352.98M
12.71%-73.3M
29.86%-58.97M
-4.77%-98.43M
-22.51%-122.28M
Net income from continuing operations
-5.05%-390.98M
8.47%-71.9M
-9.23%-91.25M
-14.99%-111.66M
-2.82%-116.16M
16.18%-372.18M
32.50%-78.56M
26.56%-83.54M
8.85%-97.1M
-5.22%-112.98M
Operating gains losses
-112.03%-194K
-120.83%-373K
349.46%232K
-1,660.00%-156K
207.29%103K
2,202.86%1.61M
1,789.62%1.79M
-126.05%-93K
--10K
---96K
Depreciation and amortization
-1.55%47.32M
-26.33%12.64M
15.20%11.68M
9.89%11.94M
11.69%11.07M
45.11%48.07M
76.69%17.16M
2.64%10.14M
38.55%10.86M
73.90%9.91M
Deferred tax
26.77%-2.07M
-88.20%184K
-58.12%-2.41M
236.35%1.99M
-30.54%-1.84M
18.71%-2.83M
188.63%1.56M
-22.37%-1.52M
-205.66%-1.46M
---1.41M
Change In working capital
80.90%-24.27M
83.22%-7.29M
30.65%-8.53M
123.74%9.19M
45.84%-17.63M
-1,847.88%-127.02M
-465.55%-43.46M
-308.91%-12.31M
-237.50%-38.71M
-153.71%-32.55M
-Change in receivables
81.05%-13.11M
-15.58%-15.69M
71.76%-6.82M
135.07%11M
-1,825.30%-1.6M
-46,335.57%-69.19M
-9,008.72%-13.57M
-73,324.24%-24.16M
-94,960.61%-31.37M
---83K
-Change in inventory
67.98%-14.21M
78.86%-4M
67.73%-3.18M
178.36%6.94M
-107.42%-13.97M
-338.64%-44.38M
-1,950.60%-18.93M
-2,885.59%-9.86M
7.23%-8.86M
---6.74M
-Change in prepaid assets
-279.70%-8.02M
87.57%-661K
212.30%2.78M
-3,163.98%-6.89M
-155.21%-3.25M
79.00%-2.11M
-3.30%-5.32M
-214.92%-2.47M
92.55%-211K
239.16%5.89M
-Change in payables and accrued expense
2,881.82%21.98M
902.62%15.96M
-95.92%1.11M
-86.15%612K
114.92%4.3M
-97.00%737K
-109.54%-1.99M
340.18%27.14M
21.44%4.42M
-378.19%-28.83M
-Change in other current liabilities
9.72%-10.9M
20.57%-2.9M
18.17%-2.41M
7.88%-2.48M
-11.62%-3.11M
-11.86%-12.07M
-34.23%-3.65M
-4.69%-2.95M
0.11%-2.69M
-8.56%-2.79M
Cash from discontinued investing activities
Operating cash flow
14.33%-302.41M
28.28%-52.57M
-33.45%-78.7M
31.48%-67.45M
15.20%-103.69M
2.44%-352.98M
12.71%-73.3M
29.86%-58.97M
-4.77%-98.43M
-22.51%-122.28M
Investing cash flow
Cash flow from continuing investing activities
149.26%47.5M
-96.73%775K
134.86%17.01M
-65.58%13.84M
114.23%15.87M
37.90%-96.41M
132.50%23.68M
38.24%-48.8M
125.65%40.22M
-172.69%-111.51M
Net PPE purchase and sale
-205.68%-33.84M
-123.61%-9.32M
-373.95%-10.84M
-1,588.01%-7.46M
-48.91%-6.21M
50.34%-11.07M
-18.11%-4.17M
36.04%-2.29M
95.36%-442K
26.36%-4.17M
Net business purchase and sale
--0
--0
--0
--0
--0
75.28%-52.57M
--0
--0
--0
---52.57M
Net investment purchase and sale
348.20%81.33M
-63.75%10.1M
159.89%27.86M
-47.61%21.3M
140.32%22.08M
-141.13%-32.77M
140.03%27.85M
35.45%-46.51M
-34.68%40.66M
-134.43%-54.76M
Cash from discontinued investing activities
Investing cash flow
149.26%47.5M
-96.73%775K
134.86%17.01M
-65.58%13.84M
114.23%15.87M
37.90%-96.41M
132.50%23.68M
38.24%-48.8M
125.65%40.22M
-172.69%-111.51M
Financing cash flow
Cash flow from continuing financing activities
-23.01%300.77M
2,332.74%56.17M
109.89%88.06M
-91.34%13.23M
-25.96%143.32M
-15.62%390.66M
140.02%2.31M
-79.31%41.95M
14,809.76%152.83M
-25.02%193.58M
Net common stock issuance
-22.90%306.31M
--55.78M
86.29%88.52M
-91.40%13.07M
-24.74%148.94M
-14.24%397.3M
--0
-76.61%47.52M
--151.87M
-23.91%197.91M
Proceeds from stock option exercised by employees
-75.47%1.53M
-73.69%839K
-99.72%2K
-65.73%669K
-95.88%15K
151.44%6.22M
178.03%3.19M
--713K
47.21%1.95M
--364K
Net other financing activities
45.10%-7.06M
49.43%-445K
92.58%-466K
49.60%-504K
-20.06%-5.64M
-360.04%-12.86M
-373.12%-880K
-1,556.20%-6.28M
-232.23%-1M
-143.70%-4.7M
Cash from discontinued financing activities
Financing cash flow
-23.01%300.77M
2,332.74%56.17M
109.89%88.06M
-91.34%13.23M
-25.96%143.32M
-15.62%390.66M
140.02%2.31M
-79.31%41.95M
14,809.76%152.83M
-25.02%193.58M
Net cash flow
Beginning cash position
-32.69%122.05M
-3.78%164.1M
-41.13%138.41M
26.62%178.05M
-32.69%122.05M
-23.87%181.32M
-48.96%170.54M
-20.69%235.11M
-74.43%140.62M
-23.87%181.32M
Current changes in cash
178.10%45.86M
109.26%4.38M
140.06%26.37M
-142.67%-40.38M
238.00%55.49M
-8.54%-58.72M
69.64%-47.31M
-265.78%-65.82M
137.89%94.62M
-112.90%-40.21M
Effect of exchange rate changes
311.46%1.14M
148.98%577K
-154.27%-680K
691.20%739K
203.46%508K
80.26%-541K
-138.99%-1.18M
162.87%1.25M
96.68%-125K
---491K
End cash Position
38.51%169.06M
38.51%169.06M
-3.78%164.1M
-41.13%138.41M
26.62%178.05M
-32.69%122.05M
-32.69%122.05M
-48.96%170.54M
-20.69%235.11M
-74.43%140.62M
Free cash flow
7.64%-336.24M
20.11%-61.89M
-46.17%-89.55M
24.24%-74.91M
13.08%-109.91M
5.22%-364.05M
11.47%-77.46M
30.12%-61.26M
4.45%-98.87M
-19.88%-126.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 14.33%-302.41M28.28%-52.57M-33.45%-78.7M31.48%-67.45M15.20%-103.69M2.44%-352.98M12.71%-73.3M29.86%-58.97M-4.77%-98.43M-22.51%-122.28M
Net income from continuing operations -5.05%-390.98M8.47%-71.9M-9.23%-91.25M-14.99%-111.66M-2.82%-116.16M16.18%-372.18M32.50%-78.56M26.56%-83.54M8.85%-97.1M-5.22%-112.98M
Operating gains losses -112.03%-194K-120.83%-373K349.46%232K-1,660.00%-156K207.29%103K2,202.86%1.61M1,789.62%1.79M-126.05%-93K--10K---96K
Depreciation and amortization -1.55%47.32M-26.33%12.64M15.20%11.68M9.89%11.94M11.69%11.07M45.11%48.07M76.69%17.16M2.64%10.14M38.55%10.86M73.90%9.91M
Deferred tax 26.77%-2.07M-88.20%184K-58.12%-2.41M236.35%1.99M-30.54%-1.84M18.71%-2.83M188.63%1.56M-22.37%-1.52M-205.66%-1.46M---1.41M
Change In working capital 80.90%-24.27M83.22%-7.29M30.65%-8.53M123.74%9.19M45.84%-17.63M-1,847.88%-127.02M-465.55%-43.46M-308.91%-12.31M-237.50%-38.71M-153.71%-32.55M
-Change in receivables 81.05%-13.11M-15.58%-15.69M71.76%-6.82M135.07%11M-1,825.30%-1.6M-46,335.57%-69.19M-9,008.72%-13.57M-73,324.24%-24.16M-94,960.61%-31.37M---83K
-Change in inventory 67.98%-14.21M78.86%-4M67.73%-3.18M178.36%6.94M-107.42%-13.97M-338.64%-44.38M-1,950.60%-18.93M-2,885.59%-9.86M7.23%-8.86M---6.74M
-Change in prepaid assets -279.70%-8.02M87.57%-661K212.30%2.78M-3,163.98%-6.89M-155.21%-3.25M79.00%-2.11M-3.30%-5.32M-214.92%-2.47M92.55%-211K239.16%5.89M
-Change in payables and accrued expense 2,881.82%21.98M902.62%15.96M-95.92%1.11M-86.15%612K114.92%4.3M-97.00%737K-109.54%-1.99M340.18%27.14M21.44%4.42M-378.19%-28.83M
-Change in other current liabilities 9.72%-10.9M20.57%-2.9M18.17%-2.41M7.88%-2.48M-11.62%-3.11M-11.86%-12.07M-34.23%-3.65M-4.69%-2.95M0.11%-2.69M-8.56%-2.79M
Cash from discontinued investing activities
Operating cash flow 14.33%-302.41M28.28%-52.57M-33.45%-78.7M31.48%-67.45M15.20%-103.69M2.44%-352.98M12.71%-73.3M29.86%-58.97M-4.77%-98.43M-22.51%-122.28M
Investing cash flow
Cash flow from continuing investing activities 149.26%47.5M-96.73%775K134.86%17.01M-65.58%13.84M114.23%15.87M37.90%-96.41M132.50%23.68M38.24%-48.8M125.65%40.22M-172.69%-111.51M
Net PPE purchase and sale -205.68%-33.84M-123.61%-9.32M-373.95%-10.84M-1,588.01%-7.46M-48.91%-6.21M50.34%-11.07M-18.11%-4.17M36.04%-2.29M95.36%-442K26.36%-4.17M
Net business purchase and sale --0--0--0--0--075.28%-52.57M--0--0--0---52.57M
Net investment purchase and sale 348.20%81.33M-63.75%10.1M159.89%27.86M-47.61%21.3M140.32%22.08M-141.13%-32.77M140.03%27.85M35.45%-46.51M-34.68%40.66M-134.43%-54.76M
Cash from discontinued investing activities
Investing cash flow 149.26%47.5M-96.73%775K134.86%17.01M-65.58%13.84M114.23%15.87M37.90%-96.41M132.50%23.68M38.24%-48.8M125.65%40.22M-172.69%-111.51M
Financing cash flow
Cash flow from continuing financing activities -23.01%300.77M2,332.74%56.17M109.89%88.06M-91.34%13.23M-25.96%143.32M-15.62%390.66M140.02%2.31M-79.31%41.95M14,809.76%152.83M-25.02%193.58M
Net common stock issuance -22.90%306.31M--55.78M86.29%88.52M-91.40%13.07M-24.74%148.94M-14.24%397.3M--0-76.61%47.52M--151.87M-23.91%197.91M
Proceeds from stock option exercised by employees -75.47%1.53M-73.69%839K-99.72%2K-65.73%669K-95.88%15K151.44%6.22M178.03%3.19M--713K47.21%1.95M--364K
Net other financing activities 45.10%-7.06M49.43%-445K92.58%-466K49.60%-504K-20.06%-5.64M-360.04%-12.86M-373.12%-880K-1,556.20%-6.28M-232.23%-1M-143.70%-4.7M
Cash from discontinued financing activities
Financing cash flow -23.01%300.77M2,332.74%56.17M109.89%88.06M-91.34%13.23M-25.96%143.32M-15.62%390.66M140.02%2.31M-79.31%41.95M14,809.76%152.83M-25.02%193.58M
Net cash flow
Beginning cash position -32.69%122.05M-3.78%164.1M-41.13%138.41M26.62%178.05M-32.69%122.05M-23.87%181.32M-48.96%170.54M-20.69%235.11M-74.43%140.62M-23.87%181.32M
Current changes in cash 178.10%45.86M109.26%4.38M140.06%26.37M-142.67%-40.38M238.00%55.49M-8.54%-58.72M69.64%-47.31M-265.78%-65.82M137.89%94.62M-112.90%-40.21M
Effect of exchange rate changes 311.46%1.14M148.98%577K-154.27%-680K691.20%739K203.46%508K80.26%-541K-138.99%-1.18M162.87%1.25M96.68%-125K---491K
End cash Position 38.51%169.06M38.51%169.06M-3.78%164.1M-41.13%138.41M26.62%178.05M-32.69%122.05M-32.69%122.05M-48.96%170.54M-20.69%235.11M-74.43%140.62M
Free cash flow 7.64%-336.24M20.11%-61.89M-46.17%-89.55M24.24%-74.91M13.08%-109.91M5.22%-364.05M11.47%-77.46M30.12%-61.26M4.45%-98.87M-19.88%-126.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.63%
Sample Name
Sample Code
 +11.47%
Sample Name
Sample Code
 +8.64%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.15%
5
United States Oil Fund LP
USO
+7.52%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +27.18%
Sample Name
Sample Code
 +19.45%
Sample Name
Sample Code
 +17.44%
4
Baidu
BIDU
+16.18%
5
Kingsoft Cloud
KC
+11.69%
View More
Middle East conflict spreads to the stock market! How should investors respond?
The negotiations between the US and Iran have entered a critical window amid external expectations and various parties' maneuvering, with th Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -